ClinicalTrials.gg
Drug

Ginkgo biloba extract clinical trials

Also written Ginkgo biloba and EGb761.

studies test it
42
open now
4
in phase 3
9
first study started
1999

How each study uses Ginkgo biloba extract is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ginkgo biloba extract studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ginkgo Biloba Extract
7
Gingko Biloba
4
EGb 761® (Tanakan®)
3

Brand

Tanakan
1

Development codes

EGb761
6

Other names

Ginkgo biloba
12
Ginkgo
2
Tebonin Forte
1

Studies by the year they started

42 studies that test it; most in 2002 (5)

Studies that test Ginkgo biloba extract, by start year
YearStudies
19991
20001
20013
20025
20033
20041
20053
20061
20071
20083
20093
20101
20111
20143
20151
20172
20201
20214
20243
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
5
Phase 2
15
Phase 3
9
Phase 4
6
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 34

Ipsen (6) · National Center for Complementary and Integrative Health (NCCIH) (5) · Beijing HuiLongGuan Hospital (3) · National Institutes of Health Clinical Center (CC) (2) · Beni-Suef University (1) · Menoufia University (1) · Nova Scotia Health Authority (1) · State University of New York College of Optometry (1)

Often tested with

Tested in the same studies.

Asian ginseng (4) · Piracetam (1) · Deamino Arginine Vasopressin (1) · Donepezil (1) · Methylprednisolone (1) · Echinacea extract (1) · Panax ginseng (1) · Curcumin (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Ginkgo biloba extract.

Studies

Open first, then newest update. How each study uses Ginkgo biloba extract is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 42

See all 42 studies that test Ginkgo biloba extract →

Given beside what is tested · 4 — Ginkgo biloba extract is usual care or a partner of the new treatment
As the comparator · 5 — what is tested is compared with Ginkgo biloba extract

Codes

What other systems call Ginkgo biloba extract · ClinicalTrials.gg INT003498

  • MeSH (NLM) C063170Ginkgo biloba extractConfirmed NLM, Wikidata
  • UNII (FDA) 19FUJ2C58TGINKGOConfirmed FDA, NLM, Wikidata
  • RxNorm 259265One source FDA
  • Wikidata Q104444041Ginkgo biloba extractConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29072GinkgoOne source FDA
  • DrugBank DB01381One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.